Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

Medigene AG. (5/24/18). "Press Release: Medigene Announces Capital Increase to Fund Immunotherapy Programs [NOT FOR UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAWS]". Pla

Organisations Organisation Medigene AG (FSE: MDG1, Prime Standard)
  Group Medigene (Group)
  Organisation 2 QVT Financial L.P.
  Group QVT (Group)
Products Product T cell therapy
  Product 2 investment banking
Index term Index term Medigene–SEVERAL: investment, 201805 private placement €32.3m 2.23m new shares at €14.5/share to institutional investors
Persons Person Manchester, Keith (QVT 201705 Managing Director + Head Life Sciences QVT Financial LP)
  Person 2 Schendel, Dolores J. (Medigene 201602– CEO before CMO before Trianta Immunotherapies + HelmholtzZentrum München)
     


   
Record changed: 2018-05-25

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for Medigene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top